相关实验视频

Updated: Sep 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

使用工程化miRNA响应性寡核酸的自我调节治疗平台

Doyeong Ku¹, Hansol Kim¹, JinA Lim¹

¹Department of Chemical and Biomolecular Engineering (BK 21+ Program), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.

Nano convergence

|June 30, 2025

概括

研究人员开发了一种新的miRNA触发器寡核酸,可以选择性地降低疾病相关的microRNAs (miRNAs). 这种方法针对抗亡基因,诱导癌细胞亡并减少体内瘤体积,建立了一个新的治疗平台.

科学领域:

分子生物学分子生物学
氧核酸治疗药物治疗药物
癌症研究癌症研究

背景情况:

微RNAs (miRNAs) 在转录后基因调节中至关重要,并与各种疾病有关.
由于其在疾病发病过程中的作用,miRNAs被认为是潜在的生物标志物和治疗点.
目前针对miRNAs的治疗策略有限.

研究的目的:

引入一种名为miRNA触发器的新型寡核酸探针,用于选择性miRNA介导的基因下调.
设计miRNA触发器以准特定的与疾病相关的miRNA及其下游影响.
评估miRNA触发剂在癌症治疗中的治疗潜力.

主要方法:

设计和合成miRNA触发性寡核酸.
工程miRNA触发器专门绑定和劫持目标miRNAs.
在癌细胞中证明了选择性mRNA下调和亡诱导.
在异种移植小鼠模型中对治疗疗效的体内验证.

主要成果:

开发的miRNA触发器通过劫持特定的miRNA选择性地降低了目标mRNA的调节.
工程化miRNA触发器诱导了乳腺癌细胞过度表达特定miRNA的亡.
在体内给予miRNA触发剂显著降低了异种移植小鼠的瘤体积.
这种方法证明了成功的治疗疗效和瘤减少.

结论:

miRNA触发器通过重定向与疾病相关的miRNAs来为寡核酸治疗提供了一个新的平台.
这项技术可以通过miRNA调制来实现向基因沉默.
这些发现支持miRNA触发器作为miRNA相关疾病,特别是癌症的新治疗策略的潜力.

关键词:

诱导亡的诱导亡.这就是BCL-xL基因.基因调节基因调节橄核酸治疗方法这就是miRNAs.

更多相关视频

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Riboswitches

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...